Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Raabe

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Endoscopy|May 1, 1982
A rare etiology of ischemic colitis - amyloid colitisJ M Perarnau, J J Raabe, A Courrier, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2001
Treatment of mild chronic hepatitis C with interferon alpha-2b: results of a multi-centre randomized study in 80 patientsP E Queneau, F Osaer, J P Bronowicki, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferonJ P Zarski, M Maynard-Muet, S Chousterman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 7, 2000
Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patientsE Boucher, D Guyader, S Jacquelinet, et al.
Scandinavian Journal of Gastroenterology|July 27, 2000
Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferonR E Poupon, A M Bonnand, P E Queneau, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Endoscopy|May 1, 1982
A rare etiology of ischemic colitis - amyloid colitisJ M Perarnau, J J Raabe, A Courrier, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2001
Treatment of mild chronic hepatitis C with interferon alpha-2b: results of a multi-centre randomized study in 80 patientsP E Queneau, F Osaer, J P Bronowicki, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferonJ P Zarski, M Maynard-Muet, S Chousterman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 7, 2000
Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patientsE Boucher, D Guyader, S Jacquelinet, et al.
Scandinavian Journal of Gastroenterology|July 27, 2000
Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferonR E Poupon, A M Bonnand, P E Queneau, et al.
Pageof 2